Evidence map›Paper›PMID 29925374›Full record

ArticleBMC biology2018

Application of long single-stranded DNA donors in genome editing: generation and validation of mouse mutants.

Gemma F Codner, Joffrey Mianné, Adam Caulder, Jorik Loeffler, Rachel Fell, Ruairidh King, Alasdair J Allan, Matthew Mackenzie, Fran J Pike, Christopher V McCabe and 12 more

Open access · goldAbstract read
In one paragraph

Article in BMC biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Comparison of CRISPR-Cas9-mediated megabase-scale genome deletion methods in mouse embryonic stem cells.DNA research : an international journal for rapid publication of reports on genes and genomes · 2023
    Article
  17. Genetic and Molecular Quality Control of Genetically Engineered Mice.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  18. Article
  19. Gene Editing in Mouse Zygotes Using the CRISPR/Cas9 System.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 1 country.

Gemma F CodnerThe Mary Lyon Centre, MRC Harwell Institute, Didcot, Oxon, OX11 0RD, UK.
Joffrey MiannéThe Mary Lyon Centre, MRC Harwell Institute, Didcot, Oxon, OX11 0RD, UK.
Adam CaulderThe Mary Lyon Centre, MRC Harwell Institute, Didcot, Oxon, OX11 0RD, UK.
Jorik LoefflerThe Mary Lyon Centre, MRC Harwell Institute, Didcot, Oxon, OX11 0RD, UK.
Rachel FellThe Mary Lyon Centre, MRC Harwell Institute, Didcot, Oxon, OX11 0RD, UK.
Ruairidh KingThe Mary Lyon Centre, MRC Harwell Institute, Didcot, Oxon, OX11 0RD, UK.
Alasdair J AllanThe Mary Lyon Centre, MRC Harwell Institute, Didcot, Oxon, OX11 0RD, UK.
Matthew MackenzieThe Mary Lyon Centre, MRC Harwell Institute, Didcot, Oxon, OX11 0RD, UK.
Fran J PikeThe Mary Lyon Centre, MRC Harwell Institute, Didcot, Oxon, OX11 0RD, UK.
Christopher V McCabeThe Mary Lyon Centre, MRC Harwell Institute, Didcot, Oxon, OX11 0RD, UK.
Skevoulla ChristouThe Mary Lyon Centre, MRC Harwell Institute, Didcot, Oxon, OX11 0RD, UK.
Sam JoynsonThe Mary Lyon Centre, MRC Harwell Institute, Didcot, Oxon, OX11 0RD, UK.
Marie HutchisonThe Mary Lyon Centre, MRC Harwell Institute, Didcot, Oxon, OX11 0RD, UK.
Michelle E StewartThe Mary Lyon Centre, MRC Harwell Institute, Didcot, Oxon, OX11 0RD, UK.
Saumya KumarMammalian Genetics Unit, MRC Harwell Institute, Didcot, Oxon, OX11 0RD, UK.
Michelle M SimonMammalian Genetics Unit, MRC Harwell Institute, Didcot, Oxon, OX11 0RD, UK.
Loranne AgiusInstitute of Cellular Medicine and Ageing and Health, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK.
Quentin M AnsteeInstitute of Cellular Medicine and Ageing and Health, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK.
Kirill E VolynskiUCL Institute of Neurology, University College London, London, WC1N 3BG, UK.
Dimitri M KullmannUCL Institute of Neurology, University College London, London, WC1N 3BG, UK.
Sara WellsThe Mary Lyon Centre, MRC Harwell Institute, Didcot, Oxon, OX11 0RD, UK.
Lydia TeboulThe Mary Lyon Centre, MRC Harwell Institute, Didcot, Oxon, OX11 0RD, UK. l.teboul@har.mrc.ac.uk.ORCID 0000-0002-2789-8637
Mary Lyon Centre at MRC Harwell · GBNewcastle University · GBUniversity College London · GB

Funding

UM1HG006348: Cas9 Genome Integrity Supplemental ProposalUM1HG006348 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI Jason D. Heaney, Chih-Wei Logan Hsu · 2016 to 2026
$47.5M
CRSPR II Supplement: Consortium for the production and cryopreservation of knockout miceU42OD011174 · OD · BAYLOR COLLEGE OF MEDICINE · PI BEAUDET, ARTHUR L. · 2012 to 2015
$17.7M
Medical Research Council 53658Medical Research Council G116/147Medical Research Council MC_UP_1502/1Medical Research Council MR/L01095X/1Medical Research Council MR/P002854/1NHGRI NIH HHS UM1 HG006348NIH HHS U42 OD011174Wellcome Trust 212285/Z/18/Z
6 · The paper itself

Abstract

backgroundRecent advances in clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) genome editing have led to the use of long single-stranded DNA (lssDNA) molecules for generating conditional mutations. However, there is still limited available data on the efficiency and reliability of this method.

resultsWe generated conditional mouse alleles using lssDNA donor templates and performed extensive characterization of the resulting mutations. We observed that the use of lssDNA molecules as donors efficiently yielded founders bearing the conditional allele, with seven out of nine projects giving rise to modified alleles. However, rearranged alleles including nucleotide changes, indels, local rearrangements and additional integrations were also frequently generated by this method. Specifically, we found that alleles containing unexpected point mutations were found in three of the nine projects analyzed. Alleles originating from illegitimate repairs or partial integration of the donor were detected in eight projects. Furthermore, additional integrations of donor molecules were identified in four out of the seven projects analyzed by copy counting. This highlighted the requirement for a thorough allele validation by polymerase chain reaction, sequencing and copy counting of the mice generated through this method. We also demonstrated the feasibility of using lssDNA donors to generate thus far problematic point mutations distant from active CRISPR cutting sites by targeting two distinct genes (Gckr and Rims1). We propose a strategy to perform extensive quality control and validation of both types of mouse models generated using lssDNA donors.

conclusionlssDNA donors reproducibly generate conditional alleles and can be used to introduce point mutations away from CRISPR/Cas9 cutting sites in mice. However, our work demonstrates that thorough quality control of new models is essential prior to reliably experimenting with mice generated by this method. These advances in genome editing techniques shift the challenge of mutagenesis from generation to the validation of new mutant models.

Indexed as

DNA, Single-StrandedGene TargetingAllelesAnimalsCRISPR-Cas SystemsGene EditingMiceMutationReproducibility of ResultsDNA, Single-StrandedAllele validationConditionalCRISPR/Cas9Homologous recombinationLong single-stranded DNAMouseMutant

Identifiers

PMID29925374
PMCPMC6011369
OpenAlexW2809309743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.